NCT04154501View on ClinicalTrials.gov

A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

August 21, 2019

Study Completion Date

August 26, 2019

Conditions
Chronic PainNociceptive PainPain
Interventions
DRUG

CNTX-6016

Oral Dose CNTX-6016

OTHER

Other: Placebo

Oral Dose Placebo

Trial Locations (1)

66212

Altasciences Clinical Research, Overland Park

Sponsors
All Listed Sponsors
lead

Centrexion Therapeutics

INDUSTRY